{
  "pmcid": "10374196",
  "sha256": "ccbbc996377a5492e1c38d6e6c53dd6cc6c4674450ce98e7714ca12e3b8a6d17",
  "timestamp_utc": "2025-11-09T15:08:22.251879+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.521401006711411,
    "reading_ease": 24.12458473154365,
    "word_count": 298
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "We tested the hypothesis that a single cryoneurolysis treatment would decrease phantom pain 4 months later."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Each received a single-injection femoral and sciatic nerve block with lidocaine and was subsequently randomized to receive either ultrasound-guided percutaneous cryoneurolysis or sham treatment at these same locations."
      },
      "Participants": {
        "score": 2,
        "evidence": "We enrolled patients with a lower-limb amputation and established phantom pain."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Each received a single-injection femoral and sciatic nerve block with lidocaine and was subsequently randomized to receive either ultrasound-guided percutaneous cryoneurolysis or sham treatment at these same locations."
      },
      "Objective": {
        "score": 1,
        "evidence": "We tested the hypothesis that a single cryoneurolysis treatment would decrease phantom pain 4 months later."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in average phantom pain intensity between baseline and 4 months as measured with a Numeric Rating Scale (0–10)."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "was subsequently randomized to receive either ultrasound-guided percutaneous cryoneurolysis or sham treatment at these same locations."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Investigators, participants, and clinical staff were masked to treatment group assignment with the exception of the treating physician performing the cryoneurolysis who had no subsequent participant interaction."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "n=71 for active treatment and n=73 for sham."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "n=71 for active treatment and n=73 for sham."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "After 4 months, pain intensity decreased by 0.5 [−0.5, 3.0] in patients given cryoneurolysis (n=71) versus 0 [0, 3] in patients given sham (n=73): estimated difference (95% CI) −0.1 (−1.0, 0.7), P=0.759."
      },
      "Harms": {
        "score": 1,
        "evidence": "One serious adverse event occurred following a protocol deviation in which a femoral nerve cryolesion was induced just below the inguinal ligament—instead of the sensory-only saphenous nerve—which resulted in quadriceps weakness, and possibly a fall and clavicle fracture."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}